image
Protagonist Therapeutics, Inc. PTGX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 41.11
0.171 %
$ 2.45 B
Market Cap
15.0
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 125.73% 36.02% 28.71%
Annual Report FY 10-K 2022-12-31 -2.84% -0.64% -4.39%
Annual Report FY 10-K 2021-12-31 -4.44% -85.38% -95.06%
Annual Report FY 10-K 2020-12-31 12293.07% 14.30% 19.88%
Annual Report FY 10-K 2019-12-31 -99.25% -98.30% -90.50%
Annual Report FY 10-K 2018-12-31 54.14% -5.32% -11.54%
Annual Report FY 10-K 2017-12-31 0.00% 0.59% -16.01%
Annual Report FY 10-K 2016-12-31 0.00% -150.22% -120.81%
Annual Report FY 10-K 2015-12-31 0.00% -34.19% -58.75%
Annual Report FY 10-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 2.62% -8.16%
Quarterly Report Q2 8-K 2024-06-30 0.00% 20.40% 8.41%
Quarterly Report Q1 8-K 2024-03-31 0.00% 759.71% 672.75%
Quarterly Report Q4 8-K 2023-12-31 0.00% 187.37% 163.12%
Quarterly Report Q3 8-K 2023-09-30 0.00% -13.08% -18.65%
Quarterly Report Q2 8-K 2023-06-30 0.00% 5.34% -2.20%
Quarterly Report Q1 8-K 2023-03-31 0.00% -51.47% -70.63%
Quarterly Report Q4 8-K 2022-12-31 0.00% 15.23% 1.35%
Quarterly Report Q3 8-K 2022-09-30 0.00% 10.78% 4.78%
Quarterly Report Q2 8-K 2022-06-30 -62.08% -31.74% -34.20%
Quarterly Report Q1 8-K 2022-03-31 315.61% 13.54% 12.11%
Quarterly Report Q4 8-K 2021-12-31 52.51% -95.42% -96.58%
Quarterly Report Q3 8-K 2021-09-30 -21.56% -335.45% -336.52%
Quarterly Report Q2 8-K 2021-06-30 -63.57% -58.81% -69.52%
Quarterly Report Q1 8-K 2021-03-31 69.70% -19.51% -21.95%
Quarterly Report Q4 8-K 2020-12-31 107.80% -7.91% -8.85%
Quarterly Report Q3 8-K 2020-09-30 216.69% 52.69% 54.73%
Quarterly Report Q2 8-K 2020-06-30 175.92% 33.43% 42.00%
Quarterly Report Q1 8-K 2020-03-31 133.78% -42.38% -34.47%
Quarterly Report Q4 8-K 2019-12-31 15.55% -26.22% -12.24%
Quarterly Report Q3 8-K 2019-09-30 -32.30% -87.85% -82.84%
Quarterly Report Q2 8-K 2019-06-30 -70.15% -236.77% -239.94%
Quarterly Report Q1 8-K 2019-03-31 -85.53% -84.09% -78.00%
Quarterly Report Q4 8-K 2018-12-31 -79.14% -354.29% -338.71%
Quarterly Report Q3 8-K 2018-09-30 -30.34% -81.04% -88.53%
Quarterly Report Q2 8-K 2018-06-30 0.00% 42.17% 38.94%
Quarterly Report Q1 8-K 2018-03-31 0.00% 45.67% 42.35%
Quarterly Report Q4 8-K 2017-12-31 0.00% 72.87% 69.18%
Quarterly Report Q3 8-K 2017-09-30 0.00% 31.89% 30.23%
Quarterly Report Q2 8-K 2017-06-30 0.00% -111.03% -113.38%
Quarterly Report Q1 8-K 2017-03-31 0.00% -20.04% -102.74%
Quarterly Report Q4 8-K 2016-12-31 0.00% -104.77% -127.89%
Quarterly Report Q3 8-K 2016-09-30 0.00% -105.39% -77.52%
Quarterly Report Q2 8-K 2016-06-30 0.00% -120.50% -130.00%
Quarterly Report Q1 8-K 2016-03-31 0.00% -335.56% -161.81%
Quarterly Report Q4 8-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%